These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Structure and dynamics of zymogen human blood coagulation factor X. Venkateswarlu D; Perera L; Darden T; Pedersen LG Biophys J; 2002 Mar; 82(3):1190-206. PubMed ID: 11867437 [TBL] [Abstract][Full Text] [Related]
32. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor. Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023 [TBL] [Abstract][Full Text] [Related]
33. Identification of an anticoagulant peptide that inhibits both fXIa and fVIIa/tissue factor from the blood-feeding nematode Ancylostoma caninum. Li D; He Q; Kang T; Yin H; Jin X; Li H; Gan W; Yang C; Hu J; Wu Y; Peng L Biochem Biophys Res Commun; 2010 Feb; 392(2):155-9. PubMed ID: 20059979 [TBL] [Abstract][Full Text] [Related]
34. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa. Wei A; Alexander RS; Duke J; Ross H; Rosenfeld SA; Chang CH J Mol Biol; 1998; 283(1):147-54. PubMed ID: 9761680 [TBL] [Abstract][Full Text] [Related]
35. Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket. Maignan S; Guilloteau JP; Choi-Sledeski YM; Becker MR; Ewing WR; Pauls HW; Spada AP; Mikol V J Med Chem; 2003 Feb; 46(5):685-90. PubMed ID: 12593649 [TBL] [Abstract][Full Text] [Related]
36. Tetrahydro-isoquinoline-based factor Xa inhibitors. Kucznierz R; Grams F; Leinert H; Marzenell K; Engh RA; von der Saal W J Med Chem; 1998 Dec; 41(25):4983-94. PubMed ID: 9836616 [TBL] [Abstract][Full Text] [Related]
37. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex. Majumder R; Quinn-Allen MA; Kane WH; Lentz BR Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797 [TBL] [Abstract][Full Text] [Related]
38. SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa. Qiao JX; Chang CH; Cheney DL; Morin PE; Wang GZ; King SR; Wang TC; Rendina AR; Luettgen JM; Knabb RM; Wexler RR; Lam PY Bioorg Med Chem Lett; 2007 Aug; 17(16):4419-27. PubMed ID: 17588746 [TBL] [Abstract][Full Text] [Related]
39. Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin. Rezaie AR; Yang L; Manithody C Biochemistry; 2004 Mar; 43(10):2898-905. PubMed ID: 15005625 [TBL] [Abstract][Full Text] [Related]
40. Cloning and characterisation of an aspartyl protease inhibitor (API-1) from Ancylostoma hookworms. Delaney A; Williamson A; Brand A; Ashcom J; Varghese G; Goud GN; Hawdon JM Int J Parasitol; 2005 Mar; 35(3):303-13. PubMed ID: 15722082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]